UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 30, 2021 4:30 P.M.
Form:
S-3
CIK:
0001372514
Company Name:
EYEGATE PHARMACEUTICALS INC
File Number:
333-255311